Intracerebral delivery of antiseizure medications by microinvasive neural implants.

Autor: Jackson HD; Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Cotler MJ; Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Saunders GW; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT 84112, USA., Cornelssen CA; Department of Biomedical Engineering, University of Utah, Salt Lake City, UT 84112, USA.; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA., West PJ; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT 84112, USA.; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA., Metcalf CS; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT 84112, USA.; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA., Wilcox KS; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT 84112, USA.; Department of Biomedical Engineering, University of Utah, Salt Lake City, UT 84112, USA.; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA., Cima MJ; Department of Materials Science and Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.